Browse by People

Up a level
Export as [feed] Atom [feed] RSS [feed] RSSPD
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 3.

Article

Morris, K.A., Golding, J.F., Blesing, C., Evans, D.G., Ferner, R.E., Foweraker, K., Halliday, D., Jena, R., McBain, C., McCabe, M.G., Swampillai, A., Warner, N., Wilson, S., Parry, A. and Afridi, S. (2016) Toxicity profile of bevacizumab in the UK Neurofibromatosis Type 2 cohort. Journal of Neuro-oncology. ISSN 0167-594X (In Press)
[img]

Ferner, R.E., Shaw, A., Evans, D.G., McAleer, D., Halliday, D., Parry, A., Raymond F, L., Durie-Gair, J., Hanemann C, O., Hornigold, R., Axon, P.R. and Golding, J.F. (2014) Longitudinal evaluation of quality of life in 288 patients with Neurofibromatosis 2. Journal of Neurology, 26 (5). pp. 936-969. ISSN 0340-5354
[img]

Ferner, R.E., Golding, John F., Smith, M., Calonje, E., Jan, W., Sanjayanathan, V. and O'Doherty, M. (2008) [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Annals of Oncology, 19 (2). pp. 390-394. ISSN 0923-7534

This list was generated on Thu Aug 25 23:32:26 2016 BST.